<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35698920</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2190-6009</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cachexia, sarcopenia and muscle</Title><ISOAbbreviation>J Cachexia Sarcopenia Muscle</ISOAbbreviation></Journal><ArticleTitle>Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors.</ArticleTitle><Pagination><StartPage>1974</StartPage><EndPage>1982</EndPage><MedlinePgn>1974-1982</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcsm.12931</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe clinical pictures and sequelae of COVID-19 disease are immune mediated and characterized by a 'cytokine storm'. Skeletal muscle has emerged as a potent regulator of immune system function. The aim of the present study is to define the prevalence of sarcopenia among COVID-19 survivors and the negative impact of sarcopenia on the post-acute COVID-19 syndrome and its related risk factors.</AbstractText><AbstractText Label="METHODS">A total of 541 subjects recovered from COVID-19 disease were enrolled in the Gemelli Against COVID-19 Post-Acute Care between April 2020 and February 2021. They underwent a multidisciplinary clinical evaluation and muscle strength and physical performance assessment.</AbstractText><AbstractText Label="RESULTS">Mean age was 53.1&#xa0;years (SD 15.2, range from 18 to 86&#xa0;years), and 274 (51%) were women. The prevalence of sarcopenia was 19.5%, and it was higher in patients with a longer hospital stay and lower in patients who were more physically active and had higher levels of serum albumin. Patients with sarcopenia had a higher number of persistent symptoms than non-sarcopenic patients (3.8&#xa0;&#xb1;&#xa0;2.9 vs. 3.2&#xa0;&#xb1;&#xa0;2.8, respectively; P&#xa0;=&#xa0;0.06), in particular fatigue, dyspnoea, and joint pain.</AbstractText><AbstractText Label="CONCLUSIONS">Sarcopenia identified according to the EWGSOP2 criteria is high in patients recovered from COVID-19 acute illness, particularly in those who had experienced the worst clinical picture reporting the persistence of fatigue and dyspnoea. Our data suggest that sarcopenia, through the persistence of inflammation, could be the biological substrate of long COVID-19 syndrome. Physical activity, especially if associated with adequate nutrition, seems to be an important protective factor.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley &amp; Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martone</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciciarello</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galluzzo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zazzara</LastName><ForeName>Maria Beatrice</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pais</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savera</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzetti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>Maria Camprubi</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Research and Development, Abbott Nutrition, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research and Development, Abbott Nutrition, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3472-1389</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Gemelli Against COVID-19 Post-Acute Care Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Abbott Nutrition</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Cachexia Sarcopenia Muscle</MedlineTA><NlmUniqueID>101552883</NlmUniqueID><ISSNLinking>2190-5991</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2754-2756. doi: 10.1002/jcsm.13108</RefSource><PMID Version="1">36251474</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055948" MajorTopicYN="Y">Sarcopenia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Personalized medicine</Keyword><Keyword MajorTopicYN="N">Sarcopenia</Keyword></KeywordList><CoiStatement>None of the participants in the Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group have any conflict of interest. M.C.R. and M.R. are employees of Abbott Nutrition.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>4</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35698920</ArticleId><ArticleId IdType="pmc">PMC9349974</ArticleId><ArticleId IdType="doi">10.1002/jcsm.12931</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cao W, Li T. COVID&#x2010;19: towards understanding of pathogenesis. Cell Res 2020;30:367&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186532</ArticleId><ArticleId IdType="pubmed">32346073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID&#x2010;19. J Infect 2020;80:607&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S, Jacob Filho W, Shinjo SK, Ferriolli E, Busse AL, Avelino&#x2010;Silva TJ, et al. Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID&#x2010;19: a prospective observational study. J Cachexia Sarcopenia Muscle 2021;10.1002/jcsm.12789</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12789</ArticleId><ArticleId IdType="pmc">PMC8661522</ArticleId><ArticleId IdType="pubmed">34523262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med 2020;383:2255&#x2013;2273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni E, Valoriani A, Cei E, Lamanna R, Gelli AMG, Ciambotti B, et al. Interleukin&#x2010;6 as prognosticator in patients with COVID&#x2010;19. J Infect 2020;81:452&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7278637</ArticleId><ArticleId IdType="pubmed">32526326</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker MS, Landmesser U, von Haehling S, Butler J, Coats AJS, Anker SD. Weight loss, malnutrition, and cachexia in COVID&#x2010;19: facts and numbers. J Cachexia Sarcopenia Muscle 2021;12:9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890265</ArticleId><ArticleId IdType="pubmed">33382211</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID&#x2010;19 patients. Emerg Microbes Infect 2020;9:761&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170362</ArticleId><ArticleId IdType="pubmed">32228226</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 2019;49:381&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945275</ArticleId><ArticleId IdType="pubmed">31662290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz&#x2010;Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy&#xe8;re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593317</ArticleId><ArticleId IdType="pubmed">31081853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiligsmann M, Beaudart C, Bruy&#xe8;re O, Biver E, Bauer J, Cruz&#x2010;Jentoft AJ, et al. Outcome priorities for older persons with sarcopenia. J Am Med Dir Assoc 2020;21:267&#x2013;271.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7021510</ArticleId><ArticleId IdType="pubmed">31672566</ArticleId></ArticleIdList></Reference><Reference><Citation>Martone AM, Marzetti E, Salini S, Zazzara MB, Santoro L, Tosato M, et al. Sarcopenia identified according to the EWGSOP2 definition in community&#x2010;living people: prevalence and clinical features. J Am Med Dir Assoc 2020;21:1470&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32359893</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Calvani R, Martone AM, Salini S, Zazzara MB, Candeloro M, et al. Normative values of muscle strength across ages in a &#x2018;real world&#x2019; population: results from the longevity check&#x2010;up 7+ project. J Cachexia Sarcopenia Muscle 2020;11:1562&#x2013;1569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749608</ArticleId><ArticleId IdType="pubmed">33147374</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Barillaro C, Bellieni A, Brandi V, Carf&#xec; A, D'Angelo M, et al. The new challenge of geriatrics: saving frail older people from the SARS&#x2010;CoV&#x2010;2 pandemic infection. J Nutr Health Aging 2020;24:466&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118362</ArticleId><ArticleId IdType="pubmed">32346682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Post&#x2010;COVID&#x2010;19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020;1&#x2013;8, 10.1007/s40520-020-01616-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotti FM, Menchinelli G, Marchetti S, Posteraro B, Landi F, Sanguinetti M, Cattani P. Assessment of SARS&#x2010;CoV&#x2010;2 RNA test results among patients who recovered from COVID&#x2010;19 with prior negative results. JAMA Intern Med 2020:e207570. 181 702&#x2013;704</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662488</ArticleId><ArticleId IdType="pubmed">33180119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID&#x2010;19 Geriatrics Team , Landi F, Barillaro C, Bellieni A, et al. The geriatrician: the frontline specialist in the treatment of COVID&#x2010;19 patients. J Am Med Dir Assoc 2020;21:937&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177102</ArticleId><ArticleId IdType="pubmed">32674823</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Persistent symptoms in patients after acute COVID&#x2010;19. JAMA 2020:e2012603. 324:605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Son BK, Lee TJ, Hwang SS. Disease severity classification and COVID&#x2010;19 outcomes, Republic of Korea. Bull World Health Organ 2021;99:62&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924894</ArticleId><ArticleId IdType="pubmed">33658735</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Calvani R, Picca A, Tosato M, D'Angelo E, Martone AM, et al. Relationship between cardiovascular health metrics and physical performance in community&#x2010;living people: results from the Longevity check&#x2010;up (Lookup) 7+ project. Sci Rep 2018;8:16353, 10.1038/s41598-018-34746-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34746-4</ArticleId><ArticleId IdType="pmc">PMC6218517</ArticleId><ArticleId IdType="pubmed">30397361</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Calvani R, Cesari M, Tosato M, Martone AM, Bernabei R, et al. Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med 2015;31:367&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">26195096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernabei R, Martone AM, Vetrano DL, Calvani R, Landi F, Marzetti E. Frailty, physical frailty, sarcopenia: a new conceptual model. Stud Health Technol Inform 2014;203:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID&#x2010;19 &#x201c;long haulers&#x201d; stump experts. JAMA 2020;324:1381&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiri D, Carf&#xec; A, Kotzalidis GD, Bernabei R, Landi F, Sani G, et al. Posttraumatic stress disorder in patients after severe COVID&#x2010;19 infection. JAMA Psychiat 2021;78:567&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893542</ArticleId><ArticleId IdType="pubmed">33599709</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID&#x2010;19. Mayo Clin Proc Innov Qual Outcomes 2020;4:764&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7661943</ArticleId><ArticleId IdType="pubmed">33204998</ArticleId></ArticleIdList></Reference><Reference><Citation>Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10:895&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2750819</ArticleId><ArticleId IdType="pubmed">19712899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain 2013;154:S10&#x2013;S28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858488</ArticleId><ArticleId IdType="pubmed">23792284</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A, et al. Sarcopenia: an overview. Aging Clin Exp Res 2017;29:11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28155183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz&#x2010;Jentoft AJ, Dent E, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle 2019;10:956&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6818450</ArticleId><ArticleId IdType="pubmed">31523937</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Marzetti E, Martone AM, Bernabei R, Onder G. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care 2014;17:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24310054</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzetti E, Picca A, Marini F, Biancolillo A, Coelho&#x2010;Junior HJ, Gervasoni J, et al. Inflammatory signatures in older persons with physical frailty and sarcopenia: the frailty &#x201c;cytokinome&#x201d; at its core. Exp Gerontol 2019;122:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">31054959</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle 2018;9:269&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5879987</ArticleId><ArticleId IdType="pubmed">29349935</ArticleId></ArticleIdList></Reference><Reference><Citation>Martone AM, Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A, et al. The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle 2017;8:907&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5700449</ArticleId><ArticleId IdType="pubmed">28913934</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Marini F, Cesari M, Buford TW, Manini TM, Pahor M, et al. Systemic inflammation, body composition, and physical performance in old community&#x2010;dwellers. J Cachexia Sarcopenia Muscle 2017;8:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5326820</ArticleId><ArticleId IdType="pubmed">27897412</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Marini F, Cesari M, Tosato M, Anker SD, von Haehling S, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle 2015;6:278&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4670735</ArticleId><ArticleId IdType="pubmed">26675566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>